PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 29 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,738 | -83.0% | 10,500 | 0.0% | 0.00% | – |
Q1 2023 | $10,248 | -6.2% | 10,500 | 0.0% | 0.00% | – |
Q4 2022 | $10,920 | -9.0% | 10,500 | 0.0% | 0.00% | – |
Q3 2022 | $12,000 | -40.0% | 10,500 | 0.0% | 0.00% | – |
Q2 2022 | $20,000 | -37.5% | 10,500 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $32,000 | -31.9% | 10,500 | -13.9% | 0.00% | 0.0% |
Q2 2021 | $47,000 | -4.1% | 12,200 | -35.8% | 0.00% | 0.0% |
Q1 2021 | $49,000 | +2.1% | 19,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $48,000 | -4.0% | 19,000 | -20.8% | 0.00% | 0.0% |
Q3 2020 | $50,000 | -35.1% | 24,000 | -3.2% | 0.00% | -50.0% |
Q2 2020 | $77,000 | +14.9% | 24,800 | -16.5% | 0.00% | 0.0% |
Q1 2020 | $67,000 | -24.7% | 29,700 | +20.2% | 0.00% | 0.0% |
Q4 2019 | $89,000 | +287.0% | 24,700 | +49.7% | 0.00% | +100.0% |
Q4 2016 | $23,000 | -14.8% | 16,500 | +10.0% | 0.00% | 0.0% |
Q3 2016 | $27,000 | +12.5% | 15,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $24,000 | -78.8% | 15,000 | -74.9% | 0.00% | -66.7% |
Q1 2016 | $113,000 | +232.4% | 59,680 | +297.9% | 0.00% | +200.0% |
Q4 2015 | $34,000 | +88.9% | 15,000 | +50.0% | 0.00% | 0.0% |
Q3 2015 | $18,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |